These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373 [TBL] [Abstract][Full Text] [Related]
5. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases. Riemsma RP; Bala MM; Wolff R; Kleijnen J Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145 [TBL] [Abstract][Full Text] [Related]
6. Transarterial embolization for large hepatocellular carcinoma with use of superabsorbent polymer microspheres: initial experience. Osuga K; Khankan AA; Hori S; Okada A; Sugiura T; Maeda M; Nagano H; Yamada A; Murakami T; Nakamura H J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 1):929-34. PubMed ID: 12354828 [TBL] [Abstract][Full Text] [Related]
7. [Embolization of the hepatic artery in primary hepatocellular carcinoma]. Shichijo Y; Inoue Y Rofo; 1985 Jul; 143(1):63-8. PubMed ID: 2992017 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model. Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058 [TBL] [Abstract][Full Text] [Related]
9. Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma. Bianco S; Merkel C; Savastano S; Bellon S; Chiesura-Corona M; Bolognesi M; Miotto D; Enzo E; Feltrin G; Gatta A Gut; 1996 Aug; 39(2):325-9. PubMed ID: 8977351 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study. Tong H; Wei B; Chen S; Xie YM; Zhang MG; Zhang LH; Huang ZY; Tang CW Oncotarget; 2017 Jul; 8(29):48303-48312. PubMed ID: 28430638 [TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154 [TBL] [Abstract][Full Text] [Related]
12. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Llovet JM; Real MI; Montaña X; Planas R; Coll S; Aponte J; Ayuso C; Sala M; Muchart J; Solà R; Rodés J; Bruix J; Lancet; 2002 May; 359(9319):1734-9. PubMed ID: 12049862 [TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Chen C; Chen PJ; Yang PM; Huang GT; Lai MY; Tsang YM; Chen DS Am J Gastroenterol; 1997 Dec; 92(12):2257-9. PubMed ID: 9399765 [TBL] [Abstract][Full Text] [Related]
15. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Kim YB; Park YN; Park C Histopathology; 2001 Feb; 38(2):160-6. PubMed ID: 11207829 [TBL] [Abstract][Full Text] [Related]
17. Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings. Chen R; Kong W; Gan Y; Ge N; Chen Y; Ding H; Luo J; Wang W; Ren Z Clin Radiol; 2019 Oct; 74(10):814.e1-814.e7. PubMed ID: 31421865 [TBL] [Abstract][Full Text] [Related]
18. Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital. Yip WM; Hung HG; Lok KH; Li KF; Li KK; Szeto ML Hong Kong Med J; 2009 Oct; 15(5):339-45. PubMed ID: 19801690 [TBL] [Abstract][Full Text] [Related]
19. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA Trials; 2012 Aug; 13():144. PubMed ID: 22913492 [TBL] [Abstract][Full Text] [Related]
20. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]